Emerging drugs for non-alcoholic fatty liver disease

Author： Federico Alessandro   Niosi Marco   Vecchio Blanco Camillo Del   Loguercio Carmela  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.13, Iss.1, 2008-03, pp. : 145-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of non-alcoholic fatty liver disease with focus on emerging drugs

By Marchesini Giulio   Moscatiello Simona   Agostini Federica   Villanova Nicola   Festi Davide  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 1, 2011-03 ,pp. : 121-136

Informa Healthcare

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease: a massive problem

By Day Christopher P  

Clinical Medicine, Vol. 11, Iss. 2, 2011-04 ,pp. : 176-178

Royal College Of Physicians

Access to resources Recommend Favorite

Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-01 ,pp. : 2193-2198

Bentham Science Publishers

Access to resources Recommend Favorite

Non Invasive Indexes for the Assessment of Patients with Non-alcoholic Fatty Liver Disease

By  

Current Pharmaceutical Design, Vol. 19, Iss. 29, 2013-09 ,pp. : 5193-5218

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for non-alcoholic steatohepatitis

By Tomeno Wataru   Yoneda Masato   Imajo Kento   Ogawa Yuji   Kessoku Takaomi   Saito Satoru   Eguchi Yuichiro   Nakajima Atsushi  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 279-290

Informa Healthcare

Access to resources Recommend Favorite